Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome | Zendy

ChiTai Fang | Zendy; WenYi Shau | Zendy; PoRen Hsueh | Zendy; YeeChun Chen | Zendy; JannTay Wang | Zendy; ChienChing Hung | Zendy; Loreen Y. L. Huang | Zendy; ShanChwen Chang | Zendy

Open Access

Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome

Author(s) -

ChiTai Fang,

WenYi Shau,

PoRen Hsueh,

YeeChun Chen,

JannTay Wang,

ChienChing Hung,

Loreen Y. L. Huang,

ShanChwen Chang

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl006

Subject(s) - glycopeptide , staphylococcus aureus , medicine , bacteremia , methicillin resistant staphylococcus aureus , microbiology and biotechnology , outcome (game theory) , micrococcaceae , staphylococcal infections , intensive care medicine , antibacterial agent , antibiotics , bacteria , biology , genetics , mathematics , mathematical economics

To evaluate whether appropriate early empirical glycopeptide therapy improves outcomes of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research